Digital education program to reduce fear of movement after heart events
Fear of MOVEment After Myocardial Infarction or Atrial Fibrillation - Patient Education Via InterneT- a Pilot Study
This study is testing a digital education program to help people who have had heart issues feel less afraid of moving and get back to being active.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 14 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Linkoeping University Government |
| Locations | 1 site (Norrköping, Ostergotland) |
| Trial ID | NCT06085508 on ClinicalTrials.gov |
What this trial studies
This project aims to evaluate the effectiveness of a digital group education program designed to reduce kinesiophobia and promote physical activity among patients who have experienced myocardial infarction (MI) and/or atrial fibrillation (AF). Over the course of eight weeks, participants will engage in seven Zoom meetings led by a nurse or physiotherapist, where they will learn about physical activity, kinesiophobia, and their heart conditions through problem-based learning and real-life scenarios. The program includes discussions, reflections, and home assignments to encourage active participation and goal setting. The feasibility of this digital education approach will also be assessed based on patient experiences.
Who should consider this trial
Good fit: Ideal candidates are patients who have experienced a myocardial infarction or atrial fibrillation and exhibit a high level of kinesiophobia.
Not a fit: Patients currently undergoing investigation for coronary artery disease or those with severe mental health issues or substance abuse problems may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could empower patients to overcome their fear of movement, leading to increased physical activity and improved recovery outcomes after heart events.
How similar studies have performed: While similar digital education approaches have shown promise in other contexts, this specific intervention targeting kinesiophobia in MI and AF patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients (n=16 with MI and/or AF with kinesiophobia score of \> 37. * Recruitment: around six months after the heart event (MI and or/AF) Exclusion Criteria: * ongoing investigation of coronary artery disease and/or atrial fibrillation or other disease that results in a negative prognosis within 1 year. * patients who have difficulty participating in and cooperating with other people in groups due to, for example, mental illness, obvious abuse of alcohol or drugs, difficulties communicating or reading the Swedish language, * or participation in other studies that may affect the results are excluded.
Where this trial is running
Norrköping, Ostergotland
- Anita Kärner Köhler — Norrköping, Ostergotland, Sweden (Recruiting)
Study contacts
- Principal investigator: Anita Kärner Köhler, Ass. prof — Linkoping University, Dept of Health, Medicine and Care
- Study coordinator: Anita Kärner Köhler, Ass. prof
- Email: anita.karner@liu.se
- Phone: +46 (0)11 363506
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.